SCHEMBL7305592

SCHEMBL7305592

CCCOc1cc(OCCC)c([O])c(OCCC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
ADORA3 P0DMS8 1/20 0.40
MAPT P10636 3/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
CASP1 P29466 1/20 0.40
HTT P42858 1/20 0.40
CASP7 P55210 1/20 0.40
ATM Q13315 1/20 0.40
CA6 P23280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2092369 0.86 PLA2G2A (0.54) KMT2AMAPTMEN1ALDH1A1TP53
SCHEMBL16575398 0.80 MAPT (0.41) KMT2AADORA3MAPTCA12CA1
SCHEMBL5252599 0.78 KMT2A (0.40) KMT2AADORA3MAPTCA12CA1
SCHEMBL7305599 0.78 LTA4H (0.47) KMT2AADORA3MAPTKDM4EMEN1
SCHEMBL9247248 0.78 KMT2A (0.40) KMT2AADORA3MAPTCA12CA1
SCHEMBL16575428 0.78 KMT2A (0.40) KMT2AADORA3MAPTCA12CA1
SCHEMBL91974 0.78 LTA4H (0.48) KMT2AMAPTCA12CA1CA2
SCHEMBL3625286 0.78 KMT2A (0.53) KMT2AMAPTKDM4EMEN1ALDH1A1
SCHEMBL7307663 0.78 CA12 (0.46) KMT2AMAPTCA12CA1CA2
SCHEMBL9311655 0.77 KMT2A (0.39) KMT2AADORA3MAPTCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed